Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   - « June » « 2025 » M T W T F S S 26 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4 5 6   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hynninen, Minna Kia
ANeED, NCT04588285: Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial	Recruiting	2	180	Europe	Ambroxol, Mucosolvan, Placebo	Helse Fonna, Klinbeforsk, Helse-Bergen HF	Dementia With Lewy Bodies	12/24	07/25
REACT MCI, NCT04792528: - Repeated Advanced Cognitive Training in Mild Cognitive Impairment	Active, not recruiting	N/A	205	Europe	Computerized cognitive training., Generalized brain training / Active control	Sorlandet Hospital HF, Oslo University Hospital, NKS Olaviken, St. Olavs Hospital, NKS Kloverasen, Barrow Neurological Institute, University of Maryland	Mild Cognitive Impairment	04/26	10/28
Olsen, Bodil S
REACT MCI, NCT04792528: - Repeated Advanced Cognitive Training in Mild Cognitive Impairment	Active, not recruiting	N/A	205	Europe	Computerized cognitive training., Generalized brain training / Active control	Sorlandet Hospital HF, Oslo University Hospital, NKS Olaviken, St. Olavs Hospital, NKS Kloverasen, Barrow Neurological Institute, University of Maryland	Mild Cognitive Impairment	04/26	10/28

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hynninen, Minna Kia
ANeED, NCT04588285: Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial	Recruiting	2	180	Europe	Ambroxol, Mucosolvan, Placebo	Helse Fonna, Klinbeforsk, Helse-Bergen HF	Dementia With Lewy Bodies	12/24	07/25
REACT MCI, NCT04792528: - Repeated Advanced Cognitive Training in Mild Cognitive Impairment	Active, not recruiting	N/A	205	Europe	Computerized cognitive training., Generalized brain training / Active control	Sorlandet Hospital HF, Oslo University Hospital, NKS Olaviken, St. Olavs Hospital, NKS Kloverasen, Barrow Neurological Institute, University of Maryland	Mild Cognitive Impairment	04/26	10/28
Olsen, Bodil S
REACT MCI, NCT04792528: - Repeated Advanced Cognitive Training in Mild Cognitive Impairment	Active, not recruiting	N/A	205	Europe	Computerized cognitive training., Generalized brain training / Active control	Sorlandet Hospital HF, Oslo University Hospital, NKS Olaviken, St. Olavs Hospital, NKS Kloverasen, Barrow Neurological Institute, University of Maryland	Mild Cognitive Impairment	04/26	10/28